Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Portfolio Pulse from Benzinga Insights
Benzinga has released its top ratings upgrades, downgrades, and initiations for August 9, 2023. Several companies have seen their ratings change, with some being upgraded to 'Buy' or 'Outperform', while others have been downgraded to 'Neutral' or 'Sell'. Notable upgrades include Mirati Therapeutics, Novavax, and Eli Lilly, while notable downgrades include Calamos Global Dynamic Income Fund, Decibel Therapeutics, and WeWork. New coverage has been initiated on Southern Co, Aytu BioPharma, and Phathom Pharmaceuticals.
August 09, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Calamos Global Dynamic Income Fund was downgraded from 'Sector Perform' to 'Underperform' by RBC Capital.
The downgrade from 'Sector Perform' to 'Underperform' suggests that the analyst sees potential for the stock's price to decrease in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Decibel Therapeutics was downgraded from 'Buy' to 'Neutral' by HC Wainwright & Co.
The downgrade from 'Buy' to 'Neutral' suggests that the analyst sees potential for the stock's price to decrease in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
WeWork was downgraded from 'Buy' to 'Neutral' by BTIG.
The downgrade from 'Buy' to 'Neutral' suggests that the analyst sees potential for the stock's price to decrease in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Maxim Group initiated coverage on Aytu BioPharma with a 'Buy' rating.
The initiation of coverage with a 'Buy' rating suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Eli Lilly was upgraded from 'Hold' to 'Buy' by Jefferies.
The upgrade from 'Hold' to 'Buy' suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Mirati Therapeutics was upgraded from 'Neutral' to 'Buy' by B. Riley Securities.
The upgrade from 'Neutral' to 'Buy' suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Novavax was upgraded from 'Neutral' to 'Buy' by B. Riley Securities.
The upgrade from 'Neutral' to 'Buy' suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co. initiated coverage on Phathom Pharmaceuticals with a 'Buy' rating.
The initiation of coverage with a 'Buy' rating suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Ladenburg Thalmann initiated coverage on Southern Co with a 'Buy' rating.
The initiation of coverage with a 'Buy' rating suggests that the analyst sees potential for the stock's price to increase in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100